Showing results (291-300 of 479) with videos related to
Sort By:
Pageof 48
Archives of Surgery (Chicago, Ill. : 1960)|October 21, 2009
Establishing standards of quality for elderly patients undergoing pancreatic resectionWande B Pratt, Anupama Gangavati, Kathryn Agarwal, et al.The Journal of Biological Chemistry|November 25, 1989
Direct evidence that the glucocorticoid receptor binds to hsp90 at or near the termination of receptor translation in vitroF C Dalman, E H Bresnick, P D Patel, et al.Investigational New Drugs|January 1, 1986
Phase I clinical and pharmacokinetic study of bisantrene in refractory pediatric solid tumorsC B Pratt, J A Sinkule, E Etcubanas, et al.The American Journal of Pediatric Hematology/Oncology|November 1, 1994
Refining therapeutic strategies for patients with resistant Wilm's tumorN M Marina, J A Wilimas, W H Meyer, et al.Cancer|June 1, 1993
A phase I study of ifosfamide given on alternate days to treat children with brain tumorsC B Pratt, E C Douglass, E H Kovnar, et al.Medical and Pediatric Oncology|May 1, 1995
Malignant melanocytic lesions of unknown primary site in children and adolescentsA S Pappo, J F Kuttesch, S C Kaste, et al.The Journal of Biological Chemistry|June 27, 1997
Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilinA M Silverstein, M D Galigniana, M S Chen, et al.Biochemistry|April 24, 2002
All of the protein interactions that link steroid receptor.hsp90.immunophilin heterocomplexes to cytoplasmic dynein are common to plant and animal cellsJennifer M Harrell, Isaac Kurek, Adina Breiman, et al.Cancer Research|December 15, 1989
Mesna excretion and ifosfamide nephrotoxicity in childrenM P Goren, C B Pratt, W H Meyer, et al.Cancer|February 15, 1990
Sarcomas (other than Ewing's) of flat bones in children and adolescents. A clinicopathologic studyS J Kellie, C B Pratt, D M Parham, et al.Pageof 48